Weikang Pharmaceutical

Hainan Weikang Pharmaceutical is a comprehensive Chinese pharmaceutical group specializing in the research, development, production, and sale of western medicine preparations and active pharmaceutical ingredients (APIs). Founded in 2002 and headquartered in Haikou, the company operates a major manufacturing hub in Qianshan, Anhui, featuring multiple GMP-certified production lines for freeze-dried powder injections and oral formulations. Its product portfolio is particularly strong in anti-infectives, gastroenterology, and neurology, with key products including cefuroxime sodium, pantoprazole sodium, and clopidogrel bisulfate. The company's R&D pipeline features clinical-stage programs such as levpantoprazole sodium for gastric disorders and lacosamide for epilepsy. Hainan Weikang is recognized as a leading manufacturer of high-end injections in China and maintains a significant presence in both domestic and international pharmaceutical markets.